The New Drug In The Clinical Trial Shows Promising Results In Reducing Tumor Of Colon Cancer

The recent clinical trial conducted in United states at Mayo Clinic revealed the new drug to reduce the effects of colon cancer.  The physicians today run out of the medicine to treat the colon cancer. The standard chemotherapy which is widely in practice is no longer showing the effective results. The new medicine that has bumped out of the clinical trial is showing the promising results today. The drug regorafenib was tested in the phase III in the clinical trial conducted with the 760 patients showed the better result over the placebo participants. The new drug, regorafenib is a multi-kinase inhibitor, which has the effect of slowing cell proliferation and blood vessel growth and tempering a variety of biological pathways that are activated in tumors. The clinical trials findings say that the patients treated with the new drug showed 29 percent progress in the survival when compared to the patients treated with placebo.